首页> 外文期刊>Renal failure. >Serum cystatin C as an endogenous marker of renal function in patients with chronic kidney disease.
【24h】

Serum cystatin C as an endogenous marker of renal function in patients with chronic kidney disease.

机译:血清胱抑素C是慢性肾脏病患者肾功能的内源性标志物。

获取原文
获取原文并翻译 | 示例
           

摘要

The estimation of the glomerular filtration rate (GFR) is an essential part of the evaluation of patients with chronic kidney disease (CKD). Recently, serum cystatin C has been proposed as a new endogenous marker of GFR. Authors compared serum creatinine, creatinine clearance calculated from Cockcroft and Gault formula and serum cystatin C against (51)CrEDTA clearance in 252 patients with CKD and GFR <90 mL/min/1.73 m(2). Analysis of correlations and diagnostic accuracy (receiver operating characteristic curves) of different GFR markers indicate that serum cystatin C is a more reliable marker of GFR in patients with CKD than serum creatinine.
机译:肾小球滤过率(GFR)的估计是评估慢性肾脏病(CKD)患者的重要组成部分。最近,血清半胱氨酸蛋白酶抑制剂C已被提议作为GFR的一种新的内源性标志物。作者比较了252例CKD和GFR <90 mL / min / 1.73 m(2)的患者的血清肌酐,根据Cockcroft和Gault公式计算的肌酐清除率以及血清胱抑素C与(51)CrEDTA清除率。对不同GFR标记物的相关性和诊断准确性(接收器工作特性曲线)的分析表明,血清半胱氨酸蛋白酶抑制剂C是CKD患者比血清肌酐更可靠的GFR标记物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号